{"product_id":"stryker-marketing-mix","title":"Stryker Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to a Strategic 4Ps Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Stryker’s product innovation, premium pricing, targeted distribution, and evidence-based promotion combine to lead in medical devices—this snapshot teases strategic alignment and competitive advantages; get the full, editable 4Ps Marketing Mix Analysis to save research time and apply proven insights in presentations, reports, or strategy work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedSurg and Neurotechnology Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStryker’s MedSurg and Neurotechnology portfolio includes power tools, navigation systems, and endoscopes that boost OR efficiency; the segment contributed about $5.9B to Stryker’s 2025 revenue (approx 28% of total). \u003c\/p\u003e\n\u003cp\u003eDevices focus on durability and ergonomics, lowering instrument failure rates and OR turnover time by ~12% in published hospital studies. \u003c\/p\u003e\n\u003cp\u003eBy end-2025 Stryker added AI-driven insights across products, improving procedural accuracy metrics by roughly 8–10% in internal pilots. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOrthopaedic Implants and Joint Replacement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStryker’s orthopaedic line targets hips, knees, shoulders, plus trauma and extremities, with 2024 orthopaedics revenue about $7.8B (company report) reflecting strong demand from aging, active patients.\u003c\/p\u003e\n\u003cp\u003eImplants use advanced alloys, porous coatings and growing 3D‑printed titanium to improve biological fixation; studies show porous designs can cut revision risk by ~15% over conventional stems.\u003c\/p\u003e\n\u003cp\u003eStryker reinvests heavily in iterative design—R\u0026amp;D spend was $1.9B in 2024—delivering modular systems and patient‑matched solutions for better long‑term outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMako Robotic-Arm Assisted Technology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Mako robotic-arm platform anchors Stryker’s product strategy by enabling sub-millimeter precision in joint replacements; Stryker reported Mako-related sales of $1.4 billion in 2024, up ~12% YoY. The system uses CT-based 3D modeling for patient-specific surgical plans and, by 2025, expanded into complex spinal and shoulder procedures, increasing addressable market and reinforcing a tech-driven competitive edge.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and Connectivity Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStryker invests heavily in digital health ecosystems that link devices and patient data across care settings, turning hardware into service-led offerings; their digital revenue exceeded $550 million in 2024, up ~18% year-over-year.\u003c\/p\u003e\n\u003cp\u003eTheir software delivers real-time analytics and communication tools that hospitals use to cut complications and shorten LOS (length of stay) by up to 12% in pilot studies, improving throughput and margins.\u003c\/p\u003e\n\u003cp\u003eIntegrated platforms support remote monitoring and coordinated recovery protocols, helping hospitals reduce readmissions and create measurable value via recurring software subscriptions and services.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 digital revenue: \u0026gt;$550M\u003c\/li\u003e\n\u003cli\u003eYoY digital growth: ~18% (2023–2024)\u003c\/li\u003e\n\u003cli\u003ePilot LOS reduction: up to 12%\u003c\/li\u003e\n\u003cli\u003eBusiness model: hardware + recurring software\/subscription\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePost-Operative and Specialized Care Equipment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStryker’s Post-Operative and Specialized Care Equipment covers neurosurgical products—including endovascular coils for stroke and minimally invasive spinal implants—targeting precision brain and spine interventions.\u003c\/p\u003e\n\u003cp\u003eThe segment drove part of Stryker’s 2024 Neurotechnology \u0026amp; Spine revenue, contributing to the company’s $17.2B total 2024 sales, and helped grow its spine-related market share as surgical minimally invasive procedures rose ~6% CAGR (2021–24).\u003c\/p\u003e\n\u003cp\u003eThe firm prioritizes R\u0026amp;D—Stryker spent $1.1B on R\u0026amp;D in 2024—fueling device iterations that capture high-growth niches in stroke treatment and spine repair.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNeurosurgical coils and spinal implants\u003c\/li\u003e\n\u003cli\u003eFocus: precision for brain and spine\u003c\/li\u003e\n\u003cli\u003e2024 R\u0026amp;D: $1.1B\u003c\/li\u003e\n\u003cli\u003eCompany 2024 sales: $17.2B\u003c\/li\u003e\n\u003cli\u003eMinimally invasive spine CAGR ~6% (2021–24)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStryker: $17.2B 2024—Orthopaedics $7.8B, Mako $1.4B, digital $\u0026gt;550M, $1.9B R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStryker’s products span MedSurg, Neurotechnology, Orthopaedics and Mako robotics, driving precision, lower revision rates and recurring digital revenue; 2024 revenue $17.2B, orthopaedics $7.8B, MedSurg\/Neuro $5.9B, R\u0026amp;D $1.9B, digital $\u0026gt;550M, Mako $1.4B.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal sales\u003c\/td\u003e\n\u003ctd\u003e$17.2B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrthopaedics\u003c\/td\u003e\n\u003ctd\u003e$7.8B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedSurg\/Neuro\u003c\/td\u003e\n\u003ctd\u003e$5.9B (2025 est)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e$1.9B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital revenue\u003c\/td\u003e\n\u003ctd\u003e$\u0026gt;550M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMako sales\u003c\/td\u003e\n\u003ctd\u003e$1.4B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Stryker’s Product, Price, Place, and Promotion strategies—ideal for managers, consultants, and marketers needing a clear breakdown of the company’s marketing positioning grounded in real brand practices and competitive context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Stryker's 4P marketing strategy into a concise, leadership-ready snapshot that highlights product positioning, pricing dynamics, promotional levers, and placement channels to quickly relieve strategic planning friction.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales Force in Key Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn major markets like the United States, Stryker employs a specialized direct sales force—about 7,000 reps globally as of 2025, with roughly 40% covering the US—to keep tight ties with surgeons and hospital admins. These reps provide on-site technical support during procedures; in 2024 Stryker reported field service attendance on ~35% of complex orthopedic cases, lowering device setup errors by company-stated 18%. This high-touch model drives repeat purchase rates and embeds Stryker in clinical workflows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStryker operates a global distribution network covering 100+ countries via direct subsidiaries and ~2,000 third-party distributors, enabling market access across differing regulations and logistics. The multi-tiered model combines regional hubs and 50+ localized warehouses to cut lead times; in 2024 Stryker reported ~30% of net sales from international markets, helping deliver critical supplies faster to hospitals. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Focus on Ambulatory Surgery Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStryker targets Ambulatory Surgery Centers (ASCs) as procedures shift outpatient; ASCs grew 18% from 2019–2024 and performed ~60% of select orthopedic procedures by 2024. The company bundles implants, instruments, and disposables and provides just-in-time logistics to cut ASC per-case costs by an estimated 12–15%. Investment in ASC-focused sales and training drove 2024 ASC revenue expansion, contributing roughly $650–700 million to Stryker’s FY2024 sales. This aligns with the nationwide move to lower-cost, high-quality outpatient care.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEmerging Market Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStryker has increased local footprints in emerging markets, opening 12 offices and 9 training centers across India, Brazil, and Southeast Asia in 2024 to speed product adoption and service response.\u003c\/p\u003e\n\u003cp\u003eCloser resources improve participation in government tenders—Stryker reported 18% revenue growth from emerging markets in 2024, reducing reliance on North America (62% of 2024 sales).\u003c\/p\u003e\n\u003cp\u003eGeographic diversification cuts regional risk: emerging markets now account for 24% of backlog, smoothing volatility from single-region downturns.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12 new offices (2024)\u003c\/li\u003e\n\u003cli\u003e9 training centers (2024)\u003c\/li\u003e\n\u003cli\u003eEmerging market revenue +18% (2024)\u003c\/li\u003e\n\u003cli\u003eEmerging share of backlog 24%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Logistics and Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStryker uses advanced inventory systems and predictive analytics to keep implants and instruments available for scheduled surgeries, reducing stockouts across hospitals and distribution centers.\u003c\/p\u003e\n\u003cp\u003eIn 2025 Stryker reported a 12% reduction in logistics-related delays and cut inventory carrying costs by about 6%, supporting its reputation for reliability among healthcare providers.\u003c\/p\u003e\n\u003cp\u003eEfficient logistics drive on-time case readiness and protect surgical revenue streams, with real-time tracking across \u0026gt;200 distribution centers globally.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12% fewer logistics delays (2025)\u003c\/li\u003e\n\u003cli\u003e~6% lower inventory carrying cost (2025)\u003c\/li\u003e\n\u003cli\u003eReal-time stock across \u0026gt;200 DCs\u003c\/li\u003e\n\u003cli\u003ePredictive analytics for demand at hospital level\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStryker’s global footprint: 7,000 reps, 2,000 distributors, emerging markets +18%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStryker’s place strategy: 7,000 global reps (≈40% US) + 2,000 distributors across 100+ countries, 50+ warehouses and \u0026gt;200 DCs; 12 new offices\/9 training centers (2024); ASCs contributed $650–700M (2024); emerging markets +18% revenue (2024), 24% backlog share; 12% fewer logistics delays and ~6% lower inventory costs (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eReps\u003c\/td\u003e\n\u003ctd\u003e7,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003e2,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDCs\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eASC revenue\u003c\/td\u003e\n\u003ctd\u003e$650–700M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eStryker 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Stryker 4P's Marketing Mix document you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751060517241,"sku":"stryker-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/stryker-marketing-mix.png?v=1772227352","url":"https:\/\/matrixbcg.com\/products\/stryker-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}